Study examines benefits of SGLT2 inhibitors in individuals with type 1 diabetes

By | November 7, 2021
In addition to lowering blood sugar levels, diabetes drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors can provide kidney- and cardiovascular-related benefits for people with type 2 diabetes.